PEDERSEN, Mikkel,PEDERSEN MIKKEL,JACOBSEN, Helle,JACOBSEN HELLE,KOEFOED, Klaus,KOEFOED KLAUS
申请号：
ES11837656
公开号：
ES2692379T3
申请日:
2011.10.31
申请国别(地区):
ES
年份:
2018
代理人:
摘要：
The present invention relates to the improved acology to receptor within her families of EGFR/ErbB/, more components of her familys (pan-HER inhibition) are more broadly interfered. More particularly it relates to use the antibody composition for being used for peoples cancer therapy. In vitro study have shown that the present invention locking it is a variety of she family receptors antibody composition better than aim at only one her family receptors antibody composition.
